BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2846304)

  • 1. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
    Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
    Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
    Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.
    Fantini J; Rognoni JB; Culouscou JM; Pommier G; Marvaldi J; Tirard A
    J Cell Physiol; 1989 Oct; 141(1):126-34. PubMed ID: 2674159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
    Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
    Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
    O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
    J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
    Fouchier F; Forget P; Pic P; Marvaldi J; Pichon J
    Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasoactive intestinal peptide receptor in a human pancreatic carcinoma cell line].
    Chen Y
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):135-7, 12. PubMed ID: 2163737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.
    Bellan C; Pic P; Marvaldi J; Fantini J; Pichon J
    Second Messengers Phosphoproteins; 1991; 13(4):163-71. PubMed ID: 1667418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
    J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
    J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP; Patel DR; Huang JX; Goetzl EJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):546-53. PubMed ID: 8390245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
    Omary MB; Kagnoff MF
    Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
    Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
    Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
    Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
    Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
    Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.